Research Society for the Study of Diabetes in India

Created by Birjesh Kumar
Last edited April 28, 2026
Research Society for the Study of Diabetes in India (RSSDI)
Formation1972
FounderProf. M.M.S. Ahuja
FieldsDiabetes care, research, and education in India
National President
Dr. Anuj Maheshwari (2026)
National President Elect
Dr. Sunil Gupta (2026)
Websitehttps://www.rssdi.in/

Research Society for the Study of Diabetes in India (RSSDI)[1] is a professional medical association dedicated to diabetes care, research, and education in India. Established in 1972, it is regarded as Asia's largest association of diabetes healthcare professionals,[2] comprising physicians, researchers, academicians, and allied health professionals involved in diabetes management.[3]

The society advances diabetes prevention and treatment through medical education, postgraduate training, research support, public awareness initiatives, and policy advocacy. RSSDI supports high-quality research through grants and multicentric studies, provides continuous medical education, and conducts nationwide programs focused on early detection and prevention of Type 2 diabetes mellitus.[4][5][6]

References[edit | edit source]

  1. "RSSDI". www.rssdi.in. Retrieved 6 February 2026.
  2. "Research Society for the Study of Diabetes in India". International Diabetes Federation. Archived from the original on 23 April 2025. Retrieved 6 February 2026.
  3. "Research Society for the Study of Diabetes in India - Gujarat Chapter | eMedEvents". www.emedevents.com. Retrieved 6 February 2026.
  4. "Research Society for the Study of Diabetes in India (RSSDI) Establishes a New Centre for Digital Diabetology with Support from the Koita Foundation". www.koitafoundation.org. Retrieved 6 February 2026.
  5. "Research Society for the Study of Diabetes in India". International Diabetes Federation. Archived from the original on 23 April 2025. Retrieved 9 February 2026.
  6. "AstraZeneca's signs MoU with Indian Diabetes Research Society (RSSDI) to empower 1 Crore Indian Diabetic patients by 2023". www.astrazeneca.com. 26 November 2020. Retrieved 9 February 2026.